Clinical Trial Update: Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) [Phase 2]

View source ↗

Summary

Phase 2 trial update for obeticholic acid in primary sclerosing cholangitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Primary Sclerosing Cholangitis (PSC) | Phase 2 | Status: COMPLETED | Results posted: 2018-05-30